Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo. [electronic resource]
Producer: 19880922Description: 337-44 p. digitalISSN:- 0149-5992
- 1-Deoxynojirimycin -- analogs & derivatives
- 3-Hydroxybutyric Acid
- Alanine -- blood
- Blood Glucose -- metabolism
- Clinical Trials as Topic
- Diabetes Mellitus, Type 2 -- blood
- Eating
- Fatty Acids, Nonesterified -- blood
- Female
- Glucosamine -- analogs & derivatives
- Glycerol -- blood
- Glycoside Hydrolase Inhibitors
- Humans
- Hydroxybutyrates -- blood
- Hypoglycemic Agents -- therapeutic use
- Imino Pyranoses
- Insulin -- blood
- Lactates -- blood
- Male
- Middle Aged
- Pyruvates -- blood
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.